Atlas Capital Advisors’s Tenet Healthcare THC Stock Holding History

Atlas Capital Advisors’s Portfolio THC Stock Details THC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.01M	Sell	5,397 -2,228	-29%	-$410K	0.11%	153
2026 Q1	$1.44M	Sell	7,625 -700	-8%	-$147K	0.16%	119
2025 Q4	$1.65M	Buy	+8,325	New	+$1.68M	0.18%	110
2025 Q2	$1.32M	Sell	7,481 -1,304	-15%	-$196K	0.16%	117
2025 Q1	$1.18M	Sell	8,785 -98	-1%	-$12.9K	0.15%	126
2024 Q4	$1.12M	Sell	8,883 -58	-0.6%	-$8.62K	0.14%	123
2024 Q3	$1.49M	Buy	8,941 +521	+6%	+$78.8K	0.23%	90
2024 Q2	$1.12M	Sell	8,420 -452	-5%	-$54.4K	0.15%	113
2024 Q1	$933K	Buy	8,872 +6,128	+223%	+$551K	0.15%	132
2023 Q4	$207K	Sell	2,744 -2,015	-42%	-$128K	0.03%	365
2023 Q3	$314K	Buy	4,759 +1,066	+29%	+$79.7K	0.05%	271
2023 Q2	$301K	Buy	+3,693	New	+$263K	0.05%	292

Other funds holding THC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

GCM

Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Atlas Capital Advisors's THC Position: Q2 2026 in Review

Atlas Capital Advisors reduced its Tenet Healthcare (THC) stake by 29% in Q2 2026, selling an estimated $410K and leaving 5,397 shares worth $1.01M. The position accounts for 0.11% of the portfolio, ranked #153.

Atlas Capital Advisors first reported a position in THC in Q2 2023 and has held it in 12 quarters since. The position peaked at $1.65M in Q4 2025. 681 funds tracked by Wall St. Rank hold THC as of Q2 2026.

Atlas Capital Advisors held 5,397 shares of Tenet Healthcare worth $1.01M as of Q2 2026.
Atlas Capital Advisors sold 2,228 Tenet Healthcare shares in Q2 2026, an estimated $410K.
Tenet Healthcare made up 0.11% of Atlas Capital Advisors's portfolio in Q2 2026, its #153 holding.
Atlas Capital Advisors first reported a position in Tenet Healthcare in Q2 2023 and has held it in 12 quarters since.
Atlas Capital Advisors's Tenet Healthcare position peaked at $1.65M in Q4 2025.
681 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2026.

Based on Atlas Capital Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.